NOVEL NITROPHENYLAZIRIDINE COMPOUNDS AND THEIR USE AS PRODRUGS
申请人:CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED
公开号:EP1109550A2
公开(公告)日:2001-06-27
US6517836B1
申请人:——
公开号:US6517836B1
公开(公告)日:2003-02-11
[EN] NOVEL NITROPHENYLAZIRIDINE COMPOUNDS AND THEIR USE AS PRODRUGS<br/>[FR] NOUVEAUX COMPOSES DE NITROPHENYLAZIRIDINE ET LEUR EMPLOI COMME PRODROGUE
申请人:CANCER RES CAMPAIGN TECH
公开号:WO2000013683A2
公开(公告)日:2000-03-16
A range of aziridin-1-yl nitrobenzamides (A-C) are provided for use as prodrugs in conjunction with nitroreductase (NR) enzymes. The amides may have 1 or 2 N-substituents which may be bulky and polar. For example, 5-(aziridin-1-yl) -N-[2-(4-morpholino) ethyl] -2,4-dinitrobenzamide of Compound (1) was found to be highly active against all NR+ cell lines tested.
Nitrophenylaziridine compounds and their use as prodrugs
申请人:Auckland Uniservices Limited
公开号:US06517836B1
公开(公告)日:2003-02-11
A range of aziridin-1-yl nitrobenzamides are provided for use as prodrugs in conjunction with nitroreductase (NR) enzymes. The amides may have 1 or 2-substituents which may be bulky and polar. For example, 5-(aziridin-1-yl)-N-[2-(4-morpholino)ethyl]-2,4-dinitrobenzamide of Formula (A) was found to be highly active against all NR+ cell lines tested.